Data / Form D filings / AmnioLife Corp
AmnioLife Corp: Form D filings
AmnioLife Corp, a biotechnology company in Gainesville, FL, filed 2 Form D notices with the SEC between 2014 and 2015. The latest, on February 25, 2015, reports $832,613 sold of a $1.6 million offering to 4 investors.
Find out what AmnioLife Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3542 NW 97TH BLVD, Gainesville, FL, 32606
- Phone
- (336) 509-6677
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1605586
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 25, 2015 | New notice | $1,550,000 | $832,613 | $717,387 | 4 | Feb 23, 2015 | sec.gov |
| Apr 15, 2014 | New notice | $500,000 | $50,000 | $450,000 | 2 | Apr 7, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian Scott Kieser | Director | |
| Gene Scott Elliot | Executive Officer, Director | |
| Thomas Christopher Broderick | Executive Officer, Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Feb 23, 2015 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AmnioLife Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.